• Eman Abd-Elfatah
  • Mamdouh El-Mekkawi
  • Emad Aboul-Soud
  • Elshaima Fawzi
  • Sherif El-Soally



This study was conducted as a field trial of using a new candidate trivalent Capripoxvirus (CaPVs) vaccine in pregnant ewes and does to detect safety degree and level of immunity, in comparison with commercial Romanian sheep pox viral (RSPPV) vaccine. Monitoring the post-vaccinal reaction and measurement of cellular and humoral immunity by evaluating the lympho­cyte proliferation assay (LPA) and serum neutralization test (SNT), respectively, in addition to detect the acquired maternal immunity in new-born lambs and kids .The post-vaccine reaction in animals vaccinated with trivalent CaPVs vaccine was more noticeable than that vaccinated with RSPPV vaccine without significant difference (P-Value>0.05). In vitro, the evaluation of cel­lular and humoral immunity revealed that the animals vaccinated with trivalent vaccine can  significantly induce lymphocyte proliferation response in addition to  of high level of antibodies (Abs) in comparison to that vaccinated with RSPPV vaccine (P-Value <0.05) with peak titre of lymphocyte proliferation and Abs titre at 10th and 28th, respectively. Furthermore, the evaluation of maternal immunity in new-born lambs and kids from previously vaccinated dams with trivalent CaPVs and RSPPV vaccines by SNT was shown that the peak level of receiving immunity was appeared at 1st week after birth with increasing its level in lambs and kids of dams vaccinated with trivalent CaPVs vaccine than those of dams vaccinated with RSPPV vaccine with a significant difference in between (P-Value <0.05). The result of this study provide a good profile about a high immune response with a long level of maternal immunity provided with trivalent CaPVs vaccine in comparison to the RSPPV vaccine so toward about the preferable use of new vaccine to control infection with sheep and goat pox diseases. Trivalent CaPVs vaccine could be candidate to be used against lumpy skin disease (LSD) due to antigenic relationship between genus CaPVs strains.

Key words: does; ewes; monovalent RSPPV; safety; trivalent CaPVs


Kitching RP, Taylor WP. Clinical and an-tigenic relationship between isolates of sheep and goatpoxviruses.Trop Anim Health Prod 1985; 17: 64–74.

Babiuk S, Bowden TR, Boyle DB, Wal-lace DB, Kitching RP. Capripoxviruses: An Emerging Worldwide Threat to Sheep, Goats and Cattle. TransbounEmerg Dis 2008; 55(7):263–72.

Buller RM, Arif BM, Black DN, Dumbell KR, Esposito JJ. Virus Taxonomy: Classifica-tion and Nomenclature of Viruses. Eighth Re-port of the International Committee on Taxon-omy of Viruses. Elsevier Academic Press, 2005;117–33.

. Rao TVS, Bandyopadhyay SK. A com-prehensive review of Goatpox and Sheeppox and their diagnosis.Anim Health Res Rev 2000; 1: 127-132.

Bhanuprakash V, Moorthy ARS, Krish-nappa G, SrinivasaGowda RN, Indrani BK. An epidemiological study of sheeppox infection in Karnataka state, India. Revue scientiet tech-nique (Inter Office of Epizo) 2005; 24 (3): 909–20.

Abu-Elzein E, Housawi F, Ramadan O. Observations on natural and experimental infec-tion of sheep and goats with a virulent field Capripoxvirus with high affinity to goat. Vet Arhiv 2003; 73(3): 119–31.

Iran Veterinary Organization. survey analysis on sheeppox and goatpox in IRAN during 2010-2014. Pox National Com-miteeBultin of Iran Vet Organization, Tehran, Iran 2013.

Kitching RP. The control of sheep and goatpox. Revue Scientiet Technique de l'OIE (France). 1986; 5:503–11.

Rweyemamu MM, Roeder PL, Taylor WP. Towards the global eradication. In: Barret T, Edn.). Cambridge: Institute of Animal Health, Biology of Animal Infection Series, Academic Press, 2006; 99–322.

Bhanuprakash V. Prospects of control and eradication of capripox from the Indian subcontinent: A perspective. Antiviral Res 2011; 91: 225–32.

Kitching RP. Vaccines for lumpyskindis-ease, sheeppox and goatpox. Develop in biolog. 2003; 114: 161–7.

Brenner J, Bellaiche M, Gross E, Elad D, Oved Z, Haimovitz M, Wasserman A, Friedgut O, Stram Y, Bumbarov V, Yadin H. Appear-ance of skin lesions in cattle populations vac-cinated against lumpyskindisease: statutory challenge. Vaccine J 2009; 27:1500–3.

Somasundaram MK. An outbreak of lumpyskindisease in a Holstein dairy herd in Oman: a clinical report. Asian J of Anim and Vet Advan 2011; 6(8):851–9

OIE (Office International des Epizooties. Sheeppox and goatpoxManual of Diagnostic Tests and Vaccines for Terrestrial Animals, Par-is.Chapter 2. 2012; 7(14):1–12.

Gelaye E, Belay A, Ayelet G, Jenberie S, Yami M, Loitsch A, Tuppurainen E, Grabher R, Diallo A, Lamien CE. Capripox disease in Ethi-opia: Genetic differences between field isolates and vaccine strain, and implications for vac-cination failure. Antiviral Res 2015; 119: 28–35.

Salib FA, Osman AH. Incidence of lumpyskindisease among Egyptian cattle in Giza Governorate, Egypt. Vet World. 2011; 4: 162–7.

Elhaig MM, Selim A, Mahmoud M.Lumpyskindisease in cattle: Frequency of occurrence in a dairy farm and a preliminary assessment of its possible impact on Egyptian buffaloes. Onderstepoort J of Vet Res 2017; 2219–35.

Fatma M Abdallah, Hend M El Damaty, Gamilat F Kotb. Sporadic cases of lumpyskin disease among cattle in Sharkia province, Egypt: Genetic characterization of lumpyskindisease virus isolates and pathological findings. Vet World. 2018; 2231–0916.

Agrawal SK, Soman JP. Assessment of immune efficacy of attenuated live goatpox vaccine against sheeppox and contagious ec-thyma.Indian Vet J 1997; 74(12): 1016–18.

Christine A Mikhael. Trialsfor preparation of improved bivalent vaccine for sheeppoxand goatpox viruses. PhD Cairo university 2012.

Christine A Mikhael, Olfat E. Na-khla,Namaa A. Mohamed. Study on the capabil-ity of a dual Capripoxvaccine in protection of cattle against LSD infection. J of vet medicine res 2017; 24 (1): 224–33.

Aboul-Soud EA, Kafafy MH, El-Suall SA, Zaghloul MA, Christine A Mikhael. Prepa-ration of trivalent vaccine against lumpy skin disease using different capripox viral strain. International J. of Vet. Science and Medicine 2018 (inpress).

Reed LJ, Muench H. Simple methods of estimating fifty percent end point .American J. of Hygi 1938; 27:493–7.

Ting A, Morris PJ. A technique for lym-phocyte preparation from stored heparinized blood. Vox.Sang.1971; 20:561–3.

Roehm NW, Rodgers GH, Hatfield SM. An improved colorimetric assay for cell prolif-eration and viability utilizing the tetrazolium salt XTT. J of immuno methods. 1991; 142:257–65.

Berridge MV, Herst PM, Tan AS. Tetrazo-lium dyes as tools in cell biology: New insights into their cellular reduction. Biotech Annual Rev 2005; 11:127–52.

Fakri F, Ghzal F, Daouam S, Elarkam A, Douieb L, Zouheir Y, Tadlaoui K, Fassi-Fihri O. Development and field application of a new combined vaccine against Peste des Petits Ru-minants and SheepPox. Trials in Vaccin.2015; 4: 33–7.

Zeidan SM, NamaaAM, Hanan MSE, Saad MAA, Olfat EN, Afaf AAW, Abeer AT, El- Dakhly AT. Preliminary study for prepara-tion of combined attenuated vaccine against sheeppox and PPR viruses. Inter. J. of Adva. Res 2016;4: 212–9.

Gari G, Abie G, Gizaw D, Wubete A, Kidane M, Asgedom H. Evaluation of the safe-ty, immuno¬genicity and efficacy of three capri-poxvirus vaccine strains against lumpy skin disease virus. Vaccine J 2015; 33(28):3256–1.

Green S, Ennis FA, Mathew A. Long term recall of memory CD8T cells in mice to first and third generation smallpox vaccines. Vaccine J 2011; 29(8):1666-–76.

Ahmed AM, Mukhtar MM, El Hussein AM, Tageidin AM, Fadol MA. Immune re-sponse of sheep vaccinated with Capripox vac-cine. Vet. Res 2007; 1(1):12–16.

Nermeen G Shafik, Ibrahim MM, Sonia A Rizk, Ali AM. Use of Different Immune Re-sponse Assays for Evaluation of Live Attenuat-ed Sheep pox Vaccine as Alternatives to Chal-lenge Test. Global J of Medical Res 2017; 17:2(1)0975–5888.

Barmana D, Chatterjee A, Guhaa C, Biswasa U, Sarkarb J, Royc TK, Roya B, Baidyad S. Estimation of post-vaccination anti-body titre against goatpox and determination of protective antibody titre. Small Rum Res 2010; 93(2): 76–8.

Gelagay A, Nigussu F, Shiferaw J, Gedlu M, Teshale S, Haileleul N. Study on immuno-genicity of combined sheep and goatpox and peste des petitis ruminants vaccines in small ruminants in Ethiopia. Afri J of Microbio Res 2012; 6: 7212–7.

Norian R, AfzalAhangran N, Varshovi HR, Azadmehr A. Comparative efficacy of two heterologous capripox vaccines to control lumpy skin disease in cattle. Bulg J of Vet Med 2017; 1311–477.

Varshovi HR, Norian R, Azadmehr A, AfzalAhangranN.Immune response characteris-tics of Capripoxvirus vaccines following emer-gency vaccination of cattle against lumpy skin disease virus. Iranian J of Vet Sci and Tech 9(2) 33-40.

Atkinson DE, Boyd RDH,Sibley CP. Pla-cental Transfer. Elsevier, Manchester press, 2000; 2787–846.

Burezq HA, Razzaque MA. Effects of immunizing pregnant ewes and does on the hu-moral immune response of secreted colostrums. J of Anim and Plant Sci 2018; 28 (1): 341–7.

Kitching P. Passive protection of sheep against Capripoxvirus. Res in vet sci 1986; 41: 247–50.

AbuElzein EME, Housawi F.M.T, Al-Afaleq AI, Ibrahim AO. Protection of Goats, with a Sheeppox Vaccine, Against a Virulent Field Capripoxvirus with High Affinity to Goats.Sci J of King Faisal Univ 2004; 5 (2): 1425.




How to Cite




Veterinary medicine: Research and application